Taking Aim at Cancer with Antibody Drugs
Guest Post by William G. Nelson, MD, PhD, Editor-in-Chief, Cancer Today Many argue that warfare metaphors, with winners and losers,...
Author:
Cancer Today Staff
Guest Post by William G. Nelson, MD, PhD, Editor-in-Chief, Cancer Today Many argue that warfare metaphors, with winners and losers,...
By Cancer Today Staff News stories about efforts to eliminate and prevent cancer often tell the story in broad...
Guest Post by William G. Nelson, MD, PhD, Editor-in-Chief, Cancer Today Nearly 85 percent of all cancer deaths in the...
Guest post by William G. Nelson, MD, PhDEditor-in-Chief, Cancer Today Mutant HRAS, KRAS, or NRAS genes have been found in...
As we celebrate National Cancer Survivor Month, we are aware how the term survivor can take on many meanings...
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today The nationwide shutdown of elective clinical procedures implemented in...
Guest Post by William G. Nelson, MD, PhDEditor-in-Chief, Cancer Today The size of the known universe is mind-boggling. At times,...
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today Cancers that grow and disseminate to threaten life reside...
Cancer researchers and cancer survivors are often viewed in separate silos. Scientists toil away alone in laboratories to decode the mechanisms of the disease and test novel molecules. Cancer...
For Bruce Hill, who was diagnosed with stage 4 clear cell renal cell carcinoma (RCC) in 2017, scientific progress...